Comment
. 2009 Mar 3;106(9):E26; author reply E27.
doi: 10.1073/pnas.0813047106.
Epub 2009 Feb 24.
Digoxin, HIF-1, and cancer
- PMID: 19240208
- PMCID: PMC2651277
- DOI: 10.1073/pnas.0813047106
Item in Clipboard
Comment
Digoxin, HIF-1, and cancer
Proc Natl Acad Sci U S A.
.
No abstract available
Conflict of interest statement
The author declares no conflict of interest.
Comment on
-
Digoxin and other cardiac glycosides inhibit HIF-1alpha synthesis and block tumor growth.Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19579-86. doi: 10.1073/pnas.0809763105. Epub 2008 Nov 19. Proc Natl Acad Sci U S A. 2008. PMID: 19020076 Free PMC article.
Similar articles
-
Low-dose anthracyclines may block HIF-1 and stop tumor growth.J Natl Cancer Inst. 2009 Mar 18;101(6):368-70. doi: 10.1093/jnci/djp052. Epub 2009 Mar 10. J Natl Cancer Inst. 2009. PMID: 19276456 No abstract available.
-
Cancer therapy by targeting hypoxia-inducible factor-1.Curr Cancer Drug Targets. 2010 Nov;10(7):782-96. doi: 10.2174/156800910793605857. Curr Cancer Drug Targets. 2010. PMID: 20578983 Review.
-
Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors.Eur J Med Chem. 2012 Mar;49:24-40. doi: 10.1016/j.ejmech.2012.01.033. Epub 2012 Jan 24. Eur J Med Chem. 2012. PMID: 22305612 Review.
-
[Research progress of hypoxia-inducible factor 1 inhibitors against tumors].Yao Xue Xue Bao. 2014 Jun;49(6):832-6. Yao Xue Xue Bao. 2014. PMID: 25212028 Review. Chinese.
-
Design, synthesis, and structure-activity relationships of 1-ethylpyrazole-3-carboxamide compounds as novel hypoxia-inducible factor (HIF)-1 inhibitors.Bioorg Med Chem. 2015 Apr 15;23(8):1776-87. doi: 10.1016/j.bmc.2015.02.038. Epub 2015 Feb 25. Bioorg Med Chem. 2015. PMID: 25773014
Cited by
-
Tapping the potential of Calotropis procera hairy roots for cardiac glycosides production and their identification using UHPLC/QTOF-MS.3 Biotech. 2024 Sep;14(9):199. doi: 10.1007/s13205-024-04035-1. Epub 2024 Aug 12. 3 Biotech. 2024. PMID: 39144068
-
Two preclinical tests to evaluate anticancer activity and to help validate drug candidates for clinical trials.Oncoscience. 2015 Feb 20;2(2):91-8. doi: 10.18632/oncoscience.132. eCollection 2015. Oncoscience. 2015. PMID: 25859551 Free PMC article.
-
Evaluating the cancer therapeutic potential of cardiac glycosides.Biomed Res Int. 2014;2014:794930. doi: 10.1155/2014/794930. Epub 2014 May 8. Biomed Res Int. 2014. PMID: 24895612 Free PMC article. Review.
-
Hypoxia-Inducible Factors and Cancer.Curr Sleep Med Rep. 2017 Mar;3(1):1-10. doi: 10.1007/s40675-017-0062-7. Epub 2017 Jan 28. Curr Sleep Med Rep. 2017. PMID: 28944164 Free PMC article.
-
Nicotine promotes proliferation of human nasopharyngeal carcinoma cells by regulating α7AChR, ERK, HIF-1α and VEGF/PEDF signaling.PLoS One. 2012;7(8):e43898. doi: 10.1371/journal.pone.0043898. Epub 2012 Aug 31. PLoS One. 2012. PMID: 22952803 Free PMC article.
References
-
- Hornestam B, Jerling M, Karlsson MO, Held P. Intravenously administered digoxin in patients with acute atrial fibrillation: A population pharmacokinetic/pharmacodynamic analysis based on the Digitalis in Acute Atrial Fibrillation trial. Eur J Clin Pharmacol. 2003;58:747–755. - PubMed
-
- Gupta RS, Chopra A, Stetsko DK. Cellular basis for the species differences in sensitivity to cardiac glycosides (digitalis) J Cell Physiol. 1986;127:197–206. - PubMed
-
- Lopez-Lazaro M, et al. Digitoxin inhibits the growth of cancer cell lines at concentrations commonly found in cardiac patients. J Nat Prod. 2005;68:1642–1645. - PubMed
-
- Lopez-Lazaro M. Digitoxin as an anticancer agent with selectivity for cancer cells: Possible mechanisms involved. Expert Opin Ther Targets. 2007;11:1043–1053. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
